4-Bromo-5-nitro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine, 97%, 10g

(R)-3-(4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid, 98%, 100mg

2,7-Dimethyl-3,5-octadiyn-2,7-diol, 98.0%, 1g

2-Methoxy-6-methylaniline>98.0%(GC)(T)25g

Rallonge à vide NS 14/23

1-(2-ethoxybenzoyl)-1,4-diazepane, 95.0%, 1g

5-Bromo-3-iodo-4-methylpyridin-2-amine, 95.0%, 1g

(R)-3-Methyl-1-phenylbutan-1-amine hydrochloride, 95.0%, 100mg

3-Amino-3-(1-(tert-butoxycarbonyl)piperidin-4-yl)propanoic acid, 95.0%, 250mg

4-(6-Chloro-pyrimidin-4-ylamino)-piperidine-1-carboxylic acid tert-butyl ester, 1g

2,5-Dimethyl 3-hydroxythiophene-2,5-dicarboxylate, 97%, 1g

Ethyl 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate, 95.0%, 250mg

5-Methylquinolin-8-ol, 95.0%, 25g